Expert assessment on volumetric laser endomicroscopy full scans in Barrett's esophagus patients with or without high grade dysplasia or early cancer.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
03 2021
Historique:
aheadofprint: 04 06 2020
pubmed: 10 6 2020
medline: 27 4 2021
entrez: 10 6 2020
Statut: ppublish

Résumé

Volumetric laser endomicroscopy (VLE) allows for near-microscopic imaging of the superficial esophageal wall and may improve detection of early neoplasia in Barrett's esophagus (BE). Interpretation of a 6-cm long, circumferential VLE "full scan" may however be challenging for endoscopists. We aimed to evaluate the accuracy of VLE experts in correctly diagnosing VLE full scans of early neoplasia and non-dysplastic BE (NDBE). 29 VLE full scan videos (15 neoplastic and 14 NDBE) were randomly evaluated by 12 VLE experts using a web-based module. Experts were blinded to the endoscopic BE images and histology. The 15 neoplastic cases contained a subtle endoscopically visible lesion, which on endoscopic resection showed high grade dysplasia or cancer. NDBE cases had no visible lesions and an absence of dysplasia in all biopsies. VLE videos were first scored as "neoplastic" or "NDBE." If neoplastic, assessors located the area most suspicious for neoplasia. Primary outcome was the performance of VLE experts in differentiating between non-dysplastic and neoplastic full scan videos, calculated by accuracy, sensitivity, and specificity. Secondary outcomes included correct location of neoplasia, interobserver agreement, and level of confidence. VLE experts correctly labelled 73 % (95 % confidence interval [CI] 67 % - 79 %) of neoplastic VLE videos. In 54 % (range 27 % - 66 %) both neoplastic diagnosis and lesion location were correct. NDBE videos were consistent with endoscopic biopsies in 52 % (95 %CI 46 % - 57 %). Interobserver agreement was fair (kappa 0.28). High level of confidence was associated with a higher rate of correct neoplastic diagnosis (81 %) and lesion location (73 %). Identification of subtle neoplastic lesions in VLE full scans by experts was disappointing. Future studies should focus on improving methodologies for reviewing full scans, development of refined VLE criteria for neoplasia, and computer-aided diagnosis of VLE scans.

Sections du résumé

BACKGROUND
Volumetric laser endomicroscopy (VLE) allows for near-microscopic imaging of the superficial esophageal wall and may improve detection of early neoplasia in Barrett's esophagus (BE). Interpretation of a 6-cm long, circumferential VLE "full scan" may however be challenging for endoscopists. We aimed to evaluate the accuracy of VLE experts in correctly diagnosing VLE full scans of early neoplasia and non-dysplastic BE (NDBE).
METHODS
29 VLE full scan videos (15 neoplastic and 14 NDBE) were randomly evaluated by 12 VLE experts using a web-based module. Experts were blinded to the endoscopic BE images and histology. The 15 neoplastic cases contained a subtle endoscopically visible lesion, which on endoscopic resection showed high grade dysplasia or cancer. NDBE cases had no visible lesions and an absence of dysplasia in all biopsies. VLE videos were first scored as "neoplastic" or "NDBE." If neoplastic, assessors located the area most suspicious for neoplasia. Primary outcome was the performance of VLE experts in differentiating between non-dysplastic and neoplastic full scan videos, calculated by accuracy, sensitivity, and specificity. Secondary outcomes included correct location of neoplasia, interobserver agreement, and level of confidence.
RESULTS
VLE experts correctly labelled 73 % (95 % confidence interval [CI] 67 % - 79 %) of neoplastic VLE videos. In 54 % (range 27 % - 66 %) both neoplastic diagnosis and lesion location were correct. NDBE videos were consistent with endoscopic biopsies in 52 % (95 %CI 46 % - 57 %). Interobserver agreement was fair (kappa 0.28). High level of confidence was associated with a higher rate of correct neoplastic diagnosis (81 %) and lesion location (73 %).
CONCLUSIONS
Identification of subtle neoplastic lesions in VLE full scans by experts was disappointing. Future studies should focus on improving methodologies for reviewing full scans, development of refined VLE criteria for neoplasia, and computer-aided diagnosis of VLE scans.

Identifiants

pubmed: 32515006
doi: 10.1055/a-1194-0397
doi:

Banques de données

ClinicalTrials.gov
['NCT03567863']

Types de publication

Clinical Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

218-225

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

B.E. Bouma: NinePoint Medical (inventor on patents and consultant), E.K. Ganguly: Boston Scientific (consultant), V.J.A. Konda: Pentax (research grant), D.K. Pleskow: NinePoint Medical (consultant), Boston Scientific/Olympus/Fujifilm/ Medtronic/CSA (consultant), A. Sethi: Boston Scientific/Olympus/Fujifilm (consultant), M.S. Smith: NinePoint Medical (consultant), A.J. Trindade: NinePoint Medical (research support), Olympus/Pentax (consultant), M.B. Wallace: NinePoint Medical (research support), Fujifilm/Boston Scientific/Olympus/ Medtronic (research grants), K.K. Wang: NinePoint Medical (research support), G.J. Tearney: NinePoint Medical (consultant and royalties), Boston Scientific (research support), iLumen (research support), C.L. Leggett: NinePoint Medical (indirect research support), J.J. Bergman: NinePoint Medical (research support), Fujifilm (speaking fees).

Auteurs

Maarten Struyvenberg (M)

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Allon Kahn (A)

Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA.

David Fleischer (D)

Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, Arizona, USA.

Anne-Fre Swager (AF)

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Brett Bouma (B)

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Eric K Ganguly (EK)

Department of Gastroenterology and Hepatology, University of Vermont Medical Center, Burlington, Vermont, USA.

Vani Konda (V)

Department of Gastroenterology and Hepatology, Baylor Scott & White Quality Alliance in Dallas, Texas, USA.

Charles J Lightdale (CJ)

Division of Gastroenterology and Hepatology, New York-Presbyterian Hospital, New York, New York, USA.

Douglas Pleskow (D)

Department of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Amrita Sethi (A)

Department of Gastroenterology and Hepatology, Columbia University Medical Center, New York, New York, USA.

Michael Smith (M)

Division of Gastroenterology and Hepatology, The Mount Sinai Hospital, New York, New York, USA.

Arvind J Trindade (AJ)

Division of Gastroenterology and Hepatology, Long Island Jewish Medical Center, New Hyde Park, New York, USA.

Michael B Wallace (MB)

Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.

Kenneth Wang (K)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Herbert C Wolfsen (HC)

Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA.

G J Tearney (GJ)

Department of Pathology, Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Wouter L Curvers (WL)

Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, The Netherlands.

Cadman L Leggett (CL)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Jacques J Bergman (JJ)

Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH